These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11080517)

  • 21. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.
    Akam EC; Carruthers AM; Nahorski SR; Challiss RA
    Br J Pharmacol; 1997 Jul; 121(6):1203-9. PubMed ID: 9249258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
    Zhang D; Li JG; Chen C; Liu-Chen LY
    Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
    Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD
    Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of receptor-mediated [35S]GTPgammaS binding to cortical membranes from postmortem human brain.
    González-Maeso J; Rodríguez-Puertas R; Gabilondo AM; Meana JJ
    Eur J Pharmacol; 2000 Feb; 390(1-2):25-36. PubMed ID: 10708703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain.
    Childers SR; Li X; Xiao R; Eisenach JC
    J Neurochem; 2005 May; 93(3):715-23. PubMed ID: 15836630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR; Nahorski SR
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional coupling between adenosine A
    Odagaki Y; Kinoshita M; Ota T; Meana JJ; Callado LF; Matsuoka I; García-Sevilla JA
    Purinergic Signal; 2018 Jun; 14(2):177-190. PubMed ID: 29492786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist-stimulated [35S]GTPgammaS autoradiography: optimization for high sensitivity.
    Happe HK; Bylund DB; Murrin LC
    Eur J Pharmacol; 2001 Jun; 422(1-3):1-13. PubMed ID: 11430907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of guanosine 5'-[gamma-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes. Regulation by nucleotides and muscarinic acetylcholine receptors.
    Hilf G; Kupprion C; Wieland T; Jakobs KH
    Eur J Biochem; 1992 Mar; 204(2):725-31. PubMed ID: 1541285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.
    Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S
    Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
    Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL
    Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg ; Mikaels ; Mohell N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.
    Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR
    Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay.
    DeLapp NW; McKinzie JH; Sawyer BD; Vandergriff A; Falcone J; McClure D; Felder CC
    J Pharmacol Exp Ther; 1999 May; 289(2):946-55. PubMed ID: 10215674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.